Oncology and Hematology
145-160 of 664
Ryan Quigley
Kathrin M. Bernt, MD
Rushabh Mehta, BS
Fatemeh Alikarami
A.J. Gelderblom, MD, PhD
- MinuteCE®
Surgical Crossroads: Practical Considerations for Optimizing Treatment in TGCT
1.00 program creditA.J. Gelderblom, MD, PhD
Michiel van de Sande, MD, PhD
- MinuteCE®
Applying the Evidence: TGCT Treatment Insights for Sports Medicine Physicians
1.00 program creditA.J. Gelderblom, MD, PhD
Chelsea Cole, MD
- MinuteCE®
Patient Perspective: Navigating TGCT Treatment—Surgery vs Systemic Therapy
1.00 program creditA.J. Gelderblom, MD, PhD
- MinuteCE®
Emerging Evidence in Focus: Interpreting Data on Next-Generation CSF1R TKIs
1.00 program creditA.J. Gelderblom, MD, PhD
A.J. Gelderblom, MD, PhD
A.J. Gelderblom, MD, PhD
Charles E. Geyer Jr., MD, FACP
A.J. Gelderblom, MD, PhD
Charles E. Geyer Jr., MD, FACP
A.J. Gelderblom, MD, PhD
Michiel van de Sande, MD, PhD
Chelsea Cole, MD
- Oncology and Hematology
Additional Safey Data From TROPION-Breast02 and Study Design of TROPION-Breast06
Komal Jhaveri, MD, FACP
- MinuteCE®
Beyond the Joint: Cross-Specialty Solutions for Advancing TGCT Patient Care
1.00 credit 10 episodesA.J. Gelderblom, MD, PhD
Michiel van de Sande, MD, PhD
Chelsea Cole, MD
Pavani Chalasani, MD, MPH
Erica L. Mayer, MD, MPH
Jacob Sands, MD
Aaron Lisberg, MD
